Victrex (LON:VCT – Get Free Report) had its price target raised by research analysts at Berenberg Bank from GBX 600 to GBX 680 in a report issued on Wednesday,London Stock Exchange reports. The firm presently has a “hold” rating on the stock. Berenberg Bank’s target price points to a potential upside of 2.26% from the company’s previous close.
Several other research analysts also recently issued reports on VCT. UBS Group reiterated a “sell” rating and issued a GBX 575 target price on shares of Victrex in a research note on Monday, May 11th. Canaccord Genuity Group cut Victrex to a “buy” rating and set a GBX 725 price target for the company. in a research note on Friday, May 15th. JPMorgan Chase & Co. lowered their price target on Victrex from GBX 725 to GBX 625 and set a “buy” rating on the stock in a report on Wednesday, March 18th. Finally, Jefferies Financial Group reiterated a “hold” rating and issued a GBX 595 price objective on shares of Victrex in a report on Tuesday. Two research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, Victrex currently has an average rating of “Hold” and a consensus target price of GBX 674.29.
Check Out Our Latest Research Report on VCT
Victrex Trading Down 1.8%
Victrex (LON:VCT – Get Free Report) last announced its earnings results on Monday, May 11th. The company reported GBX 17.20 earnings per share for the quarter. The business had revenue of £147.10 million during the quarter. Victrex had a negative net margin of 6.70% and a negative return on equity of 4.95%. As a group, sell-side analysts expect that Victrex will post 73.1078905 EPS for the current fiscal year.
Victrex Company Profile
Victrex plc, through its subsidiaries, engages in the manufacture and sale of polymer solutions worldwide. The company operates through two segments, Sustainable Solutions and Medical. It develops PEEK and PAEK based polymer solutions, and semi-finished and finished parts. The company also provides specialist solutions for medical device manufacturers; sells thermoplastic polymers; sustainable solutions for energy and industrial, VAR, automotive, aerospace, and electronics markets; and engages in trading activities.
Recommended Stories
- Five stocks we like better than Victrex
- Vertex’s Crinetics Deal Balances Growth with Integration Risk
- Stacking Chips: The Hidden Supply Shock Fueling Intel
- Drone Stocks Are Down, But Defense Backlogs Tell a Different Story
- Industrials Are Leading in 2026, But These ETFs Take Different Routes
Receive News & Ratings for Victrex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Victrex and related companies with MarketBeat.com's FREE daily email newsletter.
